Skip to content
POM-V Prescription Required Companion Animal

Metaxx 1.5 mg/ml Oral Suspension for Dogs

Active ingredient: Meloxicam

Form

Liquid

Species

Dogs

Manufacturer

Alfasan Nederland B.V.

VMD MA No.

36408/5026

What it's used for

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Metaxx 1.5 mg/ml Oral Suspension for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal
disorders in dogs.
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastrointestinal disorders such as irritation
and haemorrhage, impaired hepatic, cardiac or renal function and
haemorrhagic disorders.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients. Do not use in dogs less than 6 weeks of age.
Dogs:
FrequencyAdverse eventVery rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Appetite loss
, lethargy
,
vomiting
, diarrhoea
, blood in
faeces (occult)
, gastric
ulceration
, small intestine
ulcer
.
Renal failure
, elevated liver
enzymes
Typical adverse reactions of NSAIDs
These side effects occur generally within the first treatment week and are in
most cases transient and disappear following termination of the treatment but
may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of
a veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of
a veterinary medicinal product. Reports should be sent, preferably via a
veterinarian, to either the marketing authorisation holder or the national

Issued: May 2024
AN: 02223/2022
competent authority via the national reporting system. See the package leaflet
for respective contact details.
None

Issued: May 2024
AN: 02223/2022

Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is
a potential risk of renal toxicity.
This veterinary medicinal product for dogs should not be used in cats as it is not
suitable for use in this species. In cats, Metaxx 0.5 mg/ml oral suspension for
cats and guinea pigs should be used.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Meloxicam and other non-steroidal anti-inflammatory drugs (NSAIDs) may
cause hypersensitivity reactions. People with known hypersensitivity to NSAIDs
should avoid contact with the veterinary medicinal product. Wash hands after
use.
Accidental ingestion of the product may cause gastrointestinal effects, such as
nausea and gastric pain. Avoid accidental ingestion by children. Do not leave
the filled syringe unattended. Any uneaten medicated food must be disposed of
immediately and the bowl washed thoroughly. In case of accidental ingestion,
seek medical advice immediately and show the package leaflet or the label to
the physician.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and
substances with high protein binding may compete for binding and thus lead to
toxic effects. Meloxicam must not be administered in conjunction with other
NSAIDs or glucocorticosteroids.
Pre-treatment with anti-inflammatory substances may result in additional or
increased adverse effects and accordingly a treatment-free period with such
veterinary medicinal products should be observed for at least 24 hours before
commencement of treatment. The treatment-free period, however, should take
into account the pharmacological properties of the products used previously.
Do not refrigerate or freeze.
Not applicable
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.